China NMPA Approval Tracker
China Deals Tracker
China Biotech Fundraising Tracker
More JAK therapies for atopic dermatitis expected in China
China could soon see a stream of foreign and homegrown JAK inhibitors being cleared or tested for atopic dermatitis, as competition among local players is heating up.
China approved more drugs for atopic dermatitis in February
Chinese regulators approved 11 drugs in February. Uses and indications ran a wide gamut, including two drugs for atopic dermatitis and six new molecular entities that were approved for the first time.
Sanofi’s Dupixent approved in China for atopic dermatitis in patients aged 12 and above
This is one of the two applications that Sanofi submitted for new indication approvals.
Copyright © 2016-2022 PharmaDJ .All Rights Reserved. Suggestions and feedback: